MetaCap

Tilray Brands Inc. (TLRY)

NASDAQ: TLRYHealth Care Medicinal Chemicals and Botanical Products USD

1.89-0.18 (-8.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TLRY stock chart

Technical analysis

Key statistics

All statistics
Market cap
$279.32M
EPS (TTM)
-$1.41
52-week range
1.87 – 15.70
Day range
1.87 – 2.08
Volume / Avg
7.87M / 4.35M
Beta
—

52-week range

$1.87$15.70

TLRY stock today

Tilray Brands (TLRY) closed at $1.89 on Nov 20, down 8.70% (-$0.18), versus the S&P 500's 3.70% decline. Shares are 88.0% below their 52-week high of $15.70, set on Dec 18, 2025 and 1.1% above the 52-week low of $1.87, near the bottom of the past year's range. TLRY is down 79.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 79.2%.

Tilray Brands has posted a net loss over the last twelve months (EPS of -$1.41), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Tilray Brands

Company profile

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products.

Industry
Medicinal Chemicals and Botanical Products
CEO
Mr. Irwin David Simon
Headquarters
Leamington, ON
Employees
3,595
IPO year
2018
Website
tilray.com

Financial highlights

Full financials

In fiscal 2026, Tilray Brands generated $915.5 million in revenue, up 11.5% from fiscal 2025, its 3rd consecutive year of revenue growth. Tilray Brands reported a net loss of $121.4 million, compared with a loss of $2.19 billion a year earlier. Gross margin was 28.4% (down from 29.3%) and operating margin -6.9%.

Tilray Brands annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$915.45M$821.31M$788.94M$627.12M$628.37M
Growth+11.46%+4.10%+25.80%-0.20%+22.47%
Net income$-121.40M$-2.19B$-244.98M$-1.45B$-476.80M
EPS (diluted)$-1.09$-24.56$-3.30$-2.35$-0.99

Analyst forecast

Forecast

Consensus (10 analysts)

none

Avg. price target

$5.72+202.65%

  • Strong buy 0
  • Buy 3
  • Hold 7
  • Sell 0
  • Strong sell 0

Target range

Low $4.00High $13.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Aug/2026)
Oct 8, 2026
EPS actual vs est.
$-0.32 vs $-0.19
Surprise
-68.42%

TLRY news

All TLRY news

Tilray Brands peers

Health Care sector
TLRY peer companies
CompanyPrice% ChgMarket capCompare
ACBAurora Cannabis Inc.4.16-2.35%$273.50Mvs TLRY
SNDLSNDL Inc.1.17-5.65%$285.20Mvs TLRY
USNAUSANA Health Sciences Inc.12.94-1.67%$239.24Mvs TLRY
MDWDMediWound Ltd.13.59+0.37%$195.56Mvs TLRY
CGCCanopy Growth Corporation0.427-9.97%$191.99Mvs TLRY
NAGENiagen Bioscience Inc.1.84-1.60%$145.72Mvs TLRY
GLASGlass House Brands Inc. Subordinate Voting Shares1.18-2.48%$118.11Mvs TLRY
ISPRIspire Technology Inc.1.23-3.15%$71.05Mvs TLRY

Indexes, lists and sector

Tilray Brands stock FAQ

What is Tilray Brands's stock price today?

TLRY last traded at $1.89 as of Nov 20, 4:00 PM EST, down 8.70% on the day. Prices are delayed at least 15 minutes.

Does Tilray Brands pay a dividend?

No. Tilray Brands does not currently pay a regular cash dividend.

Who is Tilray Brands's CEO?

Mr. Irwin David Simon is the chief executive officer of Tilray Brands Inc., which has about 3,595 employees.

Has TLRY ever split its stock?

Yes. The most recent TLRY stock split was a 1-for-10 split on Dec 2, 2025.

What is the TLRY 52-week high?

The 52-week high for TLRY is $15.70 and the 52-week low is $1.87. The stock is currently 88.0% below its high.

Compare TLRY